Search clinical trials for: Phase IIb formulation

Total 10990 results

AstraZeneca

Completed

AZD9056 Relative Bioavailability Study

Healthy

United Kingdom
AstraZeneca

Completed

Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069

Uncontrolled and Persistent Asthma

United Kingdom
3D Medicines

Not yet recruiting

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Cancer Pain
Immatics Biotechnologies GmbH

Recruiting

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

Germany
Louisiana State University Health Sciences Center...

Terminated

Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

Head and Neck Squamous Cell Cancer

United States
Genentech, Inc.

Completed

Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810

Healthy Volunteer

United Kingdom
Centre Hospitalier Universitaire, Amiens
Merck Serono International SA

Completed

May Metformin be Used in Renal Failure?

Renal Disorder Associated With Type II Diabetes Mellitus

France
NTC srl

Completed

Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® (SATISFACTION)

Elective Colonoscopy

France, Germany, Italy, Russian Federation
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

Epidemic Parotitis, Mumps

China
University of Miami

Completed

CROS Application in CI (CROS)

Hearing Loss

United States
Tyligand Bioscience (Shanghai) Limited

Recruiting

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma

China
KK Women's and Children's Hospital
National University Hospital, Singapore; Singapore General Hospital

Recruiting

Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia

Lymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Lymphoblastic Leukemia, Acute Adult | Lymphoblastic Leukemia in Children | CAR

Singapore
European Institute of Oncology

Recruiting

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

Breast Cancer

Italy
Bharat Biotech International Limited
Indian Council of Medical Research

Completed

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers (BBV152)

COVID-19 | SARS-CoV-2 Infection

India
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Trials of Hypertension Prevention (TOHP)

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
Jason J. Luke, MD
Array BioPharma

Active, not recruiting

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

United States
Hillel Yaffe Medical Center

Unknown

Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.

Skin Abnormality

Israel
Boryung Pharmaceutical Co., Ltd

Active, not recruiting

BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)

Follicular Lymphoma | B Cell Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Small Lymphocytic Leukemia

Korea, Republic of, United States
Genzyme, a Sanofi Company

Completed

A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

Healthy Volunteer

United States
Immatics Biotechnologies GmbH
Bristol-Myers Squibb

Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

Germany
Hoffmann-La Roche

Completed

A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy Participants

Healthy Volunteers

United States
Chong Kun Dang Pharmaceutical

Recruiting

The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

Type 2 Diabetes

Korea, Republic of
1ST Biotherapeutics, Inc.
Merck Sharp & Dohme LLC

Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

Advanced Solid Tumor

United States
Institute of Immunology and Experimental Therapy...

Unknown

Experimental Phage Therapy of Bacterial Infections

Bacterial Infections

Poland
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Acute Gout

China
University of Oregon
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II (OSJP)

Health Behavior | Health Care Utilization

United States
Chong Kun Dang Pharmaceutical

Unknown

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

GERD

Korea, Republic of
Tillotts Pharma AG
University Hospital, Basel, Switzerland; University of Basel; SocraTec R&D GmbH; Swiss Commission for Technology and Innovation

Completed

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

Healthy

Switzerland
Werium Assistive Solutions

Enrolling by invitation

Clinical Study of the Effects of a SWalker II and VR for Hip Fracture Rehabilitation in the Elderly (SWalker-VR)

Hip Fractures | Gait Disorders in Old Age

Spain
University of Missouri-Columbia

Completed

The Liver Health Study for Patients With NAFLD

Obesity | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
AtlasMedx, Incorporated

Active, not recruiting

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Homologous Recombination Deficiency | Advanced Malignant Neoplasm

United States
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate the PK and Safety of CKD-393

Type II Diabetes

Korea, Republic of
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

A Study of HS-20089 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Taipei Medical University WanFang Hospital

Recruiting

Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction

Acute Myocardial Infarction

Taiwan
CStone Pharmaceuticals
Blueprint Medicines Corporation

Completed

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sinotau Pharmaceutical Group

Not yet recruiting

Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer

Prostate Cancer

China
Kyushu University

Recruiting

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

Gastric Cancer | Pancreatic Cancer

Japan
AstraZeneca

Completed

To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers

Parkinson's Disease

United Kingdom
H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program; Bankhead-Coley Florida Biomedical...

Completed

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

Adenocarcinoma | Lung Cancer

United States
John A Widness
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Red Blood Cell (RBC) Survival Following Transfusion in Infants

Neonatal Anemia

United States
Centre Georges Francois Leclerc

Not yet recruiting

Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. (IMMUNOMEK)

Non-Small Cell Lung Cancer
Janssen Sciences Ireland UC

Completed

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Healthy

United Kingdom
National Heart and Lung Institute
Royal Brompton & Harefield NHS Foundation Trust

Completed

The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X

Microvascular Angina

United Kingdom
Memorial Sloan Kettering Cancer Center

Recruiting

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Small Cell Lung Carcinoma | Small Cell Lung Cancer

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of JNJ-42756493 Tablets

Healthy

Belgium
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety Profile of CKD-333

Hypertension | Dyslipidemias

Korea, Republic of
GlaxoSmithKline

Completed

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Multiple Sclerosis

Poland, Germany, Czechia
Wake Forest University Health Sciences
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Healthy Living Partnership to Prevent Diabetes (HELP PD)

Obesity | Prediabetes

United States
Pfizer

Completed

Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers

Healthy

Singapore
Ruijin Hospital

Recruiting

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

Esophageal Cancer | Salvage Radiotherapy | Dose-escalation | Mediastinal Lymph Node Recurrence

China

Search clinical trials for: Phase IIb formulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations